We are live on ! Find out more
MA

Marshwinds Advisory Portfolio holdings

AUM $187M
1-Year Est. Return 1.79%
This Fund
S&P 500
This Quarter Est. Return
+7.7%
1 Year Est. Return
-1.79%
3 Year Est. Return
+32.92%
5 Year Est. Return
+52.83%
10 Year Est. Return
AUM
$192M
AUM Growth
+$5.22M
Cap. Flow
-$8.12M
Cap. Flow %
-4.24%
Top 10 Hldgs %
26.18%
Holding
143
New
1
Increased
11
Reduced
83
Closed
9

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$213K
2
XOM icon
ExxonMobil
XOM
+$12.5K
3
JPM icon
JPMorgan Chase
JPM
+$651
4
WFC icon
Wells Fargo
WFC
+$597
5
ABT icon
Abbott
ABT
+$132

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$936K
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$628K
3
MSFT icon
Microsoft
MSFT
+$457K
4
AMGN icon
Amgen
AMGN
+$377K
5
MMM icon
3M
MMM
+$315K

Sector Composition

Rank Sector Weight
1 Healthcare 17.3%
2 Consumer Staples 17%
3 Industrials 16.81%
4 Technology 15.55%
5 Communication Services 6.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STJ
26
DELISTED
St Jude Medical
STJ
$2.69M 1.41%
43,615
-425
-1% -$26.8K
COP icon
27
ConocoPhillips
COP
$147B
$2.67M 1.39%
57,161
-866
-1% -$45.3K
VZ icon
28
Verizon
VZ
$195B
$2.6M 1.36%
56,309
-1,625
-3% -$73.8K
TR icon
29
Tootsie Roll Industries
TR
$2.93B
$2.6M 1.36%
114,019
-713
-0.6% -$16.4K
DUK icon
30
Duke Energy
DUK
$97.8B
$2.51M 1.31%
35,142
-1,681
-5% -$118K
ED icon
31
Consolidated Edison
ED
$40.1B
$2.33M 1.22%
36,259
-1,600
-4% -$103K
CVX icon
32
Chevron
CVX
$392B
$2.05M 1.07%
22,753
-483
-2% -$43.6K
JNJ icon
33
Johnson & Johnson
JNJ
$618B
$2.04M 1.07%
19,885
-2,043
-9% -$205K
GD icon
34
General Dynamics
GD
$104B
$2.03M 1.06%
14,770
-275
-2% -$39.3K
META icon
35
Meta Platforms (Facebook)
META
$1.42T
$1.97M 1.03%
18,860
-3,000
-14% -$308K
DIS icon
36
Walt Disney
DIS
$167B
$1.9M 0.99%
18,112
TSS
37
DELISTED
Total System Services, Inc.
TSS
$1.83M 0.96%
36,817
-200
-0.5% -$10.4K
PEP icon
38
PepsiCo
PEP
$190B
$1.81M 0.95%
18,158
PPG icon
39
PPG Industries
PPG
$24.6B
$1.75M 0.92%
17,750
-1,150
-6% -$116K
ESE icon
40
ESCO Technologies
ESE
$8.17B
$1.74M 0.91%
48,070
ABBV icon
41
AbbVie
ABBV
$443B
$1.51M 0.79%
25,436
MDT icon
42
Medtronic
MDT
$109B
$1.43M 0.75%
18,627
-1,550
-8% -$117K
ADSK icon
43
Autodesk
ADSK
$49.5B
$1.42M 0.74%
23,275
-150
-0.6% -$8.71K
SYK icon
44
Stryker
SYK
$125B
$1.41M 0.73%
15,125
-525
-3% -$50.2K
TT icon
45
Trane Technologies
TT
$101B
$1.4M 0.73%
25,300
IFF icon
46
International Flavors & Fragrances
IFF
$20.2B
$1.38M 0.72%
11,550
-100
-0.9% -$11.6K
NWL icon
47
Newell Brands
NWL
$2.38B
$1.37M 0.71%
31,025
-500
-2% -$21.9K
WY icon
48
Weyerhaeuser
WY
$18B
$1.34M 0.7%
44,659
-98
-0.2% -$2.96K
DTE icon
49
DTE Energy
DTE
$29.5B
$1.3M 0.68%
19,103
-147
-0.8% -$10.1K
ABT icon
50
Abbott
ABT
$183B
$1.28M 0.67%
28,554
+3
+0% +$132

Similar funds

Marshwinds Advisory's Q4 2015 Portfolio in Review

As of Q4 2015, Marshwinds Advisory held 143 positions worth $192M, up 2.8% from $186M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Marshwinds Advisory withdrew a net $8.12M in Q4 2015, closing 9 positions and reducing 83 holdings. Its most notable exit was Apple, an estimated $936K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, Marshwinds Advisory opened a new position in Thermo Fisher Scientific worth $227K.

  • Marshwinds Advisory's largest Q4 2015 buy was Thermo Fisher Scientific: 1,600 shares worth $227K.
  • Marshwinds Advisory added most to ExxonMobil in Q4 2015, an estimated $12.5K increase.
  • Marshwinds Advisory's biggest Q4 2015 reduction was Microsoft, cutting an estimated $457K.
  • Marshwinds Advisory fully exited Apple in Q4 2015, selling an estimated $936K.
  • Marshwinds Advisory's ten largest holdings make up 26% of its $192M portfolio in Q4 2015.
  • Marshwinds Advisory opened 1 new position and closed 9 in Q4 2015.
  • Marshwinds Advisory's portfolio value rose 2.8% quarter-over-quarter to $192M.

Based on Marshwinds Advisory's 13F filing for Q4 2015, filed 8 Jan 2016.